Rithm Capital (STU:14N1) Research & Development: €0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:14N1 Rithm Capital Corp STU:14N1
49 GF Score
Price €8.02
GF Value €8.98
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Rithm Capital Research & Development?

Rithm Capital STU:14N1 -0.25% 49 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates STU:14N1 with a GF Score™ of 49/100 and a GF Value™ of €8.98 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rithm Capital's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Rithm Capital  (STU:14N1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rithm Capital Research & Development Related Terms

Rithm Capital Research & Development Historical Data

* Premium members only.

The historical data trend for Rithm Capital's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rithm Capital Research & Development Chart

Rithm Capital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Rithm Capital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:14N1
49GF Score
Rithm Capital Corp STU:14N1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rithm Capital Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Rithm Capital (STU:14N1) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Rithm Capital and its competitors.
Is Rithm Capital's Research & Development too high?
Rithm Capital's current Research & Development is €0 Mil. Overall, Rithm Capital has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rithm Capital's Research & Development compare to STWD and BXMT?
Rithm Capital's Research & Development of €0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rithm Capital and its competitors. Rithm Capital's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rithm Capital stock overvalued right now?
Based on GuruFocus' analysis, Rithm Capital (STU:14N1) is currently considered Fairly Valued. The stock's GF Value™ is €8.98, compared to a current price of €8.02 — trading 10.7% below its estimated fair value. The current Research & Development is €0 Mil. Rithm Capital's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rithm Capital (STU:14N1), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rithm Capital (STU:14N1) Overvalued in 2026?

Based on GuruFocus' analysis, Rithm Capital stock appears to be undervalued. The current stock price of €8.02 is trading 10.7% below its estimated GF Value™ of €8.98. GuruFocus considers Rithm Capital to be Fairly Valued.

Key valuation signals for STU:14N1:

  • Research & Development: €0 Mil
  • GF Value™: €8.98 vs. price of €8.02 (10.7% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the STU:14N1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rithm Capital Business Description

Industry Real EstateREITs
Address 799 Broadway, New York, NY, USA, 10003
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.
49GF Score

Get the complete analysis for STU:14N1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.02
Price
€8.98
GF Value